Privia Health Shares Advance on Outlook Bump From Medicare Savings
By Dean Seal
Shares of Privia Health rose after the company said its networks of hospitals and healthcare providers generated $233 million in savings for 2024 through a Medicare program.
The stock was up 6% at $23.12 on Friday. Shares are now up 18% since the start of the year.
The company, which provides tools and technology to doctors and health systems, said its Accountable Care Organizations notched shared savings of $233.1 million through the Medicare Shared Savings Program for 2024. That's up 32% from 2023.
The program allows Accountable Care Organizations, or groups of doctors and hospitals, to work on lowering costs for Medicare beneficiaries and then share the savings they achieve.
Based on the savings achieved, Privia bumped up its full-year guidance for adjusted earnings before interest, taxes, depreciation and amortization to a range of $113 million to $116 million. It was previously targeting about $110 million.
The outlook raise is preliminary, given that Privia is only halfway through the third quarter, the company said. It expects to provide another update on guidance when it next reports quarterly results in early November.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
August 29, 2025 14:43 ET (18:43 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
The 7 Best Dividend Aristocrats to Buy Now for the Long Term
The 10 Best Companies to Invest in Now
This Turnaround Stock Is Up and Still 38% Undervalued
7 Stocks to Buy That Can Move the Market
